Y-mAbs

+$1.44 (+4.40%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Y-mAbs and other stocks, options, and ETFs commission-free!

About YMAB

Y-mAbs Therapeutics, Inc. Common Stock, also called Y-mAbs, is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer.

CEO
Claus Juan Møller-San Pedro
Employees
125
Headquarters
New York, New York
Founded
2015

YMAB Key Statistics

Market Cap
1.48B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
337.08K
High Today
$34.41
Low Today
$32.69
Open Price
$32.94
Volume
215.71K
52 Week High
$55.22
52 Week Low
$24.78

YMAB Earnings

-$1.01
-$0.42
$0.16
$0.75
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$0.19 per share
Actual
$0.75 per share
Replay Earnings Call

You May Also Like

PTPI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure